{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:12:10Z","timestamp":1789506730151,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007062","name":"Yangzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128996","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:07:31Z","timestamp":1785697651000},"page":"128996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intranasal immunization with a P1 adhesin C-terminal-flagellin fusion protein elicits robust systemic and mucosal immunity and protects against Mycoplasma pneumoniae infection in a mouse model"],"prefix":"10.1016","volume":"88","author":[{"given":"Jingni","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128996_bb0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12879-017-2500-z","article-title":"Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of mycoplasma pneumoniae pneumonia","volume":"17","author":"Yoon","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128996_bb0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/cix378","article-title":"Microorganisms associated with pneumonia in children <5 years of age in developing and emerging countries: the GABRIEL pneumonia multicenter, prospective, Case-Control Study","volume":"65","author":"B\u00e9net","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128996_bb0015","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900112","article-title":"Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016","volume":"25","author":"Beeton","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128996_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00344-0","article-title":"Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions","volume":"5","author":"Meyer Sauteur","year":"2024","journal-title":"Lancet Microbe."},{"key":"10.1016\/j.vaccine.2026.128996_bb0025","article-title":"Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study","volume":"6","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2026.128996_bb0030","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s10096-021-04171-z","article-title":"Mycoplasma pneumoniae may cause dyspnoea and hospitalisations in young healthy adults","volume":"40","author":"Mets\u00e4l\u00e4","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128996_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103863","article-title":"Mycoplasma pneumoniae-related hepatitis in children","volume":"139","author":"Poddighe","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2026.128996_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00406-8","article-title":"Pneumonia outbreaks due to re-emergence of mycoplasma pneumoniae","volume":"5","author":"Meyer Sauteur","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2026.128996_bb0045","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/QCO.0000000000001126","article-title":"Resurgence of mycoplasma pneumoniae infections in children: emerging challenges and opportunities","volume":"38","author":"de Groot","year":"2025","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128996_bb0050","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3201\/eid2706.203206","article-title":"Macrolide-resistant mycoplasma pneumoniae infections in children, Ohio, USA","volume":"27","author":"Lanata","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128996_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102930","article-title":"Clinical impact of rapid test for macrolide-resistance gene mutation among cases with mycoplasma pneumoniae in Japan","volume":"18","author":"Murata","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2026.128996_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.128996_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","article-title":"Current status of mycoplasma pneumoniae infection in China","volume":"20","author":"Yan","year":"2024","journal-title":"World J Pediatr"},{"key":"10.1016\/j.vaccine.2026.128996_bb0070","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1038\/s41467-020-18777-y","article-title":"Immunodominant proteins P1 and P40\/P90 from human pathogen mycoplasma pneumoniae","volume":"11","author":"Vizarraga","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128996_bb0075","article-title":"An mRNA vaccine targeting the C-terminal region of P1 protein induces an immune response and protects against mycoplasma pneumoniae","volume":"26","author":"Zhang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2026.128996_bb0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1139\/w2012-051","article-title":"Protective efficacy of a mycoplasma pneumoniae P1C DNA vaccine fused with the B subunit of Escherichia coli heat-labile enterotoxin","volume":"58","author":"Zhu","year":"2012","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.vaccine.2026.128996_bb0085","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128996_bb0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ni1344","article-title":"Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1\u03b2 via Ipaf","volume":"7","author":"Miao","year":"2006","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128996_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/imm.70001","article-title":"Flagellins as vaccine adjuvants and Cancer immunotherapy: recent advances and future prospects","volume":"176","author":"Talukder","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2026.128996_bb0100","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2017.09.070","article-title":"A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin\/F1\/V, in healthy adult volunteers (DMID 08-0066)","volume":"35","author":"Frey","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128996_bb0105","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128996_bb0110","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.1215584","article-title":"Structural basis of TLR5-flagellin recognition and signaling","volume":"335","author":"Yoon","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128996_bb0115","doi-asserted-by":"crossref","first-page":"11191","DOI":"10.1038\/s41598-017-10247-8","article-title":"Second-generation Flagellin-rPAc fusion protein, KFD2-rPAc, shows high protective efficacy against dental caries with low potential side effects","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128996_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109401","article-title":"A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant","volume":"36","author":"Zhao","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2026.128996_bb0125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2010.01.077","article-title":"Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2026.128996_bb0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.vaccine.2018.12.009","article-title":"Recombinant flagellins with deletions in domains D1, D2, and D3: characterization as novel immunoadjuvants","volume":"37","author":"Biedma","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128996_bb0135","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1016\/j.vaccine.2012.06.086","article-title":"Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response","volume":"30","author":"Taylor","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128996_bb0140","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1128\/IAI.00224-10","article-title":"Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection","volume":"78","author":"Mu\u00f1oz","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128996_bb0145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41385-018-0104-6","article-title":"A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases","volume":"12","author":"Puth","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2026.128996_bb0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4161\/hv.23809","article-title":"Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization","volume":"9","author":"Yang","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128996_bb0155","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41423-022-00929-3","article-title":"A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern","volume":"19","author":"Yang","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2026.128996_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128767","article-title":"Optimized flagellin enhances systemic and mucosal immune responses induced by SARS-CoV-2 virus-like particle vaccines","volume":"87","author":"Song","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128996_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111530","article-title":"The mechanism of baicalin in improving pulmonary inflammatory response and injury and regulating intestinal flora in mycoplasma pneumoniae pneumonia mice","volume":"126","author":"Song","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.vaccine.2026.128996_bb0170","article-title":"Intranasal immunization with a c-di-GMP-Adjuvanted acellular pertussis vaccine provides superior immunity against Bordetella pertussis in a mouse model","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128996_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0732-8893(02)00484-4","article-title":"Development of a multiplex real-time quantitative PCR assay to detect chlamydia pneumoniae, legionella pneumophila and mycoplasma pneumoniae in respiratory tract secretions","volume":"45","author":"Welti","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128996_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-018-0433-5","article-title":"Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes","volume":"25","author":"Stepanova","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2026.128996_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110295","article-title":"Flagellin as a versatile adjuvant platform: genetic fusion approaches for next-generation vaccines","volume":"26","author":"Mardanova","year":"2025","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.vaccine.2026.128996_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin-a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.vaccine.2026.128996_bb0195","doi-asserted-by":"crossref","first-page":"13242","DOI":"10.1073\/pnas.1710433114","article-title":"Broad detection of bacterial type III secretion system and flagellin proteins by the human NAIP\/NLRC4 inflammasome","volume":"114","author":"Reyes Ruiz","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.128996_bb0200","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature10510","article-title":"The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus","volume":"477","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128996_bb0205","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1189\/jlb.3HI0816-368RR","article-title":"Frontline science: nasal epithelial GM-CSF contributes to TLR5-mediated modulation of airway dendritic cells and subsequent IgA response","volume":"102","author":"Cao","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2026.128996_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.08.017","article-title":"Mucosal plasma cells are required to protect the upper airway and brain from infection","volume":"55","author":"Wellford","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128996_bb0215","article-title":"Long-lasting mucosal and systemic immunity against influenza A virus is significantly prolonged and protective by nasal whole influenza immunization with mucosal adjuvant N3 and DNA-plasmid expressing flagellin in aging in- and outbred mice","volume":"7","author":"Hinkula","year":"2019","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.vaccine.2026.128996_bb0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41392-024-01822-3","article-title":"Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.128996_bb0225","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00129-2021","article-title":"M ycoplasma pneumoniae carriage evades induction of protective mucosal antibodies","volume":"59","author":"de Groot","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2026.128996_bb0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/infdis\/jix559","article-title":"The role of B cells in carriage and clearance of Mycoplasma pneumoniae from the respiratory tract of mice","volume":"217","author":"Meyer Sauteur","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128996_bb0235","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.128996_bb0240","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.micinf.2006.10.012","article-title":"IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory mycoplasma pneumoniae infection","volume":"9","author":"Wu","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2026.128996_bb0245","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.128996_bb0250","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.4049\/jimmunol.172.11.6875","article-title":"The upper and lower respiratory tracts differ in their requirement of IFN-gamma and IL-4 in controlling respiratory mycoplasma infection and disease","volume":"172","author":"Woolard","year":"2004","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:48:06Z","timestamp":1789505286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0264410X26008054"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128996","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunization with a P1 adhesin C-terminal-flagellin fusion protein elicits robust systemic and mucosal immunity and protects against Mycoplasma pneumoniae infection in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128996"}}